Topline safety and efficacy update of SUPLEXA-101, a first-in-human, single agent study of SUPLEXA therapeutic cells in 28 patients with metastatic solid tumours

SUPLEXA cell therapy - Alloplex Biotherap

https://jitc.bmj.com/content/11/Suppl_1/A822

Rohit Joshi1; Jeffrey Goh2; Sharron Gargosky3; Ganessan Kitchenadasse4; Victoria Atkinson5; Warren Joubert6; Vineet Kwatra1; Meena Okera7; Sarwan Bishnoi7; George Nisyrios4; James A Lederer8; Frank Borriello3

Sep 27, 2023